Brett Sandercock - 27 Nov 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
27 Nov 2023
Transactions value $
-$457,860
Form type
4
Filing time
29 Nov 2023, 19:45:21 UTC
Previous filing
18 Aug 2023
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$458K -3K -3.13% $152.62 93K 27 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 47.925 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.